Spectrum Pharmatech Consultants Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 15-06-2024
- Paid Up Capital ₹ 5.00 M
as on 15-06-2024
- Company Age 22 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 46.20 Cr
as on 15-06-2024
- Satisfied Charges ₹ 12.00 Cr
as on 15-06-2024
- Revenue -30.10%
(FY 2023)
- Profit 41.54%
(FY 2023)
- Ebitda 131.36%
(FY 2023)
- Net Worth 4.86%
(FY 2023)
- Total Assets -0.66%
(FY 2023)
About Spectrum Pharmatech Consultants
The Company is engaged in the Engineering Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹46.20 Cr. The company has closed loans amounting to ₹12.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Swaminathan Subramaniam, Padma Swaminathan, and Aniruddha Parmar serve as directors at the Company.
- CIN/LLPIN
U74999MH2002PTC137116
- Company No.
137116
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Sep 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Spectrum Pharmatech Consultants Private Limited offer?
Spectrum Pharmatech Consultants Private Limited offers a wide range of products and services, including Architectural & Civil Engineering, Architectural Services.
Who are the key members and board of directors at Spectrum Pharmatech Consultants?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Swaminathan Subramaniam  | Director | 19-Sep-2002 | Current |
| Padma Swaminathan | Director | 19-Sep-2002 | Current |
| Aniruddha Parmar | Director | 19-Sep-2002 | Current |
Financial Performance of Spectrum Pharmatech Consultants.
Spectrum Pharmatech Consultants Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 30.1% decrease. The company also saw a substantial improvement in profitability, with a 41.54% increase in profit. The company's net worth moved up by a moderate rise of 4.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Spectrum Pharmatech Consultants?
In 2023, Spectrum Pharmatech Consultants had a promoter holding of 92.32% and a public holding of 7.68%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Proworks Engineering And Technical Services Private LimitedActive 14 years 6 monthsSwaminathan Subramaniam is a mutual person
Spectrum Progrow Advisors Private LimitedActive 14 years 6 monthsSwaminathan Subramaniam and Aniruddha Parmar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Feb 2023 | ₹11.50 Cr | Open |
Others Creation Date: 27 Feb 2023 | ₹4.00 Cr | Open |
Others Creation Date: 07 Feb 2023 | ₹2.50 Cr | Open |
How Many Employees Work at Spectrum Pharmatech Consultants?
Spectrum Pharmatech Consultants has a workforce of 126 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Spectrum Pharmatech Consultants, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spectrum Pharmatech Consultants's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
